As of 3:59pm ET
| -0.03 / -1.70%|
The 4 analysts offering 12-month price forecasts for Idera Pharmaceuticals Inc have a median target of 5.50, with a high estimate of 8.00 and a low estimate of 4.00. The median estimate represents a +217.92% increase from the last price of 1.73.
The current consensus among 5 polled investment analysts is to Buy stock in Idera Pharmaceuticals Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.